190 related articles for article (PubMed ID: 34745385)
1. Ral GEF with the PH Domain and SH3 Binding Motif 1 Regulated by Splicing Factor Junction Plakoglobin and Pyrimidine Metabolism Are Prognostic in Uterine Carcinosarcoma.
Guo H; Wang S; Xie A; Sun W; Wei C; Xian S; Yin H; Li M; Sun H; Li H; Meng T; Zhang J; Huang Z
Dis Markers; 2021; 2021():1484227. PubMed ID: 34745385
[TBL] [Abstract][Full Text] [Related]
2. Germ Cell-Specific Gene 1-Like Protein Regulated by Splicing Factor CUGBP Elav-Like Family Member 5 and Primary Bile Acid Biosynthesis are Prognostic in Glioblastoma Multiforme.
Huang R; Li Z; Li C; Wang G; Yan P; Peng L; Wang J; Zhu X; Hu P; Zhang J; Chang Z; Huang Z; Cheng L; Zhang J
Front Genet; 2019; 10():1380. PubMed ID: 32117422
[TBL] [Abstract][Full Text] [Related]
3. Identification of drug targets and prognosis projection for uterine carcinosarcoma based on alternative splicing events.
Zhang X; Yin X; Zhang L; Ye Z; Liang G
Comput Biol Med; 2023 Jan; 152():106346. PubMed ID: 36470146
[TBL] [Abstract][Full Text] [Related]
4. Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma.
Meng T; Huang R; Zeng Z; Huang Z; Yin H; Jiao C; Yan P; Hu P; Zhu X; Li Z; Song D; Zhang J; Cheng L
Front Bioeng Biotechnol; 2019; 7():270. PubMed ID: 31681747
[No Abstract] [Full Text] [Related]
5. Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma.
Huang R; Yan G; Sun H; Zhang J; Song D; Kong R; Yan P; Hu P; Xie A; Wang S; Zhuang J; Yin H; Meng T; Huang Z
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32627826
[TBL] [Abstract][Full Text] [Related]
6. The Construction of Bone Metastasis-Specific Prognostic Model and Co-expressed Network of Alternative Splicing in Breast Cancer.
Huang R; Guo J; Yan P; Zhai S; Hu P; Zhu X; Zhang J; Qiao Y; Zhang Y; Liu H; Huang L; Zhang J; Yang D; Huang Z
Front Cell Dev Biol; 2020; 8():790. PubMed ID: 32984314
[TBL] [Abstract][Full Text] [Related]
7. Co-expression Analysis of Genes and Tumor-Infiltrating Immune Cells in Metastatic Uterine Carcinosarcoma.
Huang R; Sun H; Yan G; Zhang L; Sun W; Zhang J; Yin H; Xian S; Hu P; Yan P; Zhu X; Meng T; Wang J; Huang Z
Reprod Sci; 2021 Sep; 28(9):2685-2698. PubMed ID: 33905082
[TBL] [Abstract][Full Text] [Related]
8. The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators.
Zou Z; Zhou S; Liang G; Tang Z; Li K; Tan S; Zhang X; Zhu X
Mol Omics; 2021 Jun; 17(3):438-453. PubMed ID: 34110327
[TBL] [Abstract][Full Text] [Related]
9. OSucs: An Online Prognostic Biomarker Analysis Tool for Uterine Carcinosarcoma.
An Y; Wang Q; Sun F; Zhang G; Wang F; Zhang L; Li Y; Ren W; Zhu W; Li Y; Ji S; Guo X
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899312
[TBL] [Abstract][Full Text] [Related]
10. The Identification of Prognostic and Metastatic Alternative Splicing in Skin Cutaneous Melanoma.
Huang R; Li M; Zeng Z; Zhang J; Song D; Hu P; Yan P; Xian S; Zhu X; Chang Z; Zhang J; Guo J; Yin H; Meng T; Huang Z
Cancer Control; 2022; 29():10732748211051554. PubMed ID: 34986671
[TBL] [Abstract][Full Text] [Related]
11. Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods.
Cai Q; He B; Zhang P; Zhao Z; Peng X; Zhang Y; Xie H; Wang X
J Transl Med; 2020 Dec; 18(1):463. PubMed ID: 33287830
[TBL] [Abstract][Full Text] [Related]
12. HDAC Inhibition Induces Cell Cycle Arrest and Mesenchymal-Epithelial Transition in a Novel Pleural-Effusion Derived Uterine Carcinosarcoma Cell Line.
Stockhammer P; Okumus Ö; Hegedus L; Rittler D; Ploenes T; Herold T; Kalbourtzis S; Bankfalvi A; Sucker A; Kimmig R; Aigner C; Hegedus B
Pathol Oncol Res; 2021; 27():636088. PubMed ID: 34257602
[No Abstract] [Full Text] [Related]
13. Identification of prognostic and bone metastatic alternative splicing signatures in bladder cancer.
Huang R; Zheng Z; Xian S; Zhang J; Jia J; Song D; Yan P; Yin H; Hu P; Zhu X; Huang Z; Meng T; Zhang J
Bioengineered; 2021 Dec; 12(1):5289-5304. PubMed ID: 34402716
[TBL] [Abstract][Full Text] [Related]
14. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma.
Lai J; Yang H; Xu T
BMC Cancer; 2021 Jul; 21(1):848. PubMed ID: 34294080
[TBL] [Abstract][Full Text] [Related]
15. Systematic analysis of the relationship between ovarian cancer prognosis and alternative splicing.
Zhang D; Zou D; Deng Y; Yang L
J Ovarian Res; 2021 Sep; 14(1):120. PubMed ID: 34526089
[TBL] [Abstract][Full Text] [Related]
16. RNA-seq Identification of RACGAP1 as a Metastatic Driver in Uterine Carcinosarcoma.
Mi S; Lin M; Brouwer-Visser J; Heim J; Smotkin D; Hebert T; Gunter MJ; Goldberg GL; Zheng D; Huang GS
Clin Cancer Res; 2016 Sep; 22(18):4676-86. PubMed ID: 27121792
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronan-mediated motility receptor expression functions as a prognostic biomarker in uterine carcinosarcoma based on bioinformatics analysis.
Sun H; Ma L; Chen J
J Int Med Res; 2021 Jun; 49(6):3000605211021043. PubMed ID: 34111996
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and status of hormone receptors and angiogenic factors in uterine carcinosarcoma.
Etoh T; Nakai H
J Obstet Gynaecol Res; 2014 Mar; 40(3):820-5. PubMed ID: 24320058
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value and Potential Role of Alternative mRNA Splicing Events in Cervical Cancer.
Shao XY; Dong J; Zhang H; Wu YS; Zheng L
Front Genet; 2020; 11():726. PubMed ID: 32793282
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological and gene mutation characteristics of uterine carcinosarcoma].
Tu J; Xu JZ; Zhang YS; Deng LF
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(24):1864-1867. PubMed ID: 37357193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
